Epigenic Therapeutics

Company profile

Epigenic Therapeutics company profile

Epigenic Therapeutics is a biotechnology company focused on developing next-generation gene modulation therapies through the regulation of epigenetic mechanisms. The proprietary EPIREG™ technology platform allows for efficient, durable, and specific silencing of target genes via accurate DNA methylation and histone modification. In contrast to traditional gene-editing methods that depend on DNA cleavage, EPIREG™ presents a safer and groundbreaking therapeutic solution for individuals with chronic conditions, effectively addressing the safety issues linked to conventional gene editing. The company has pioneered two main technologies: epigenetic modulation and in-vivo lipid nanoparticle (LNP) delivery systems, which enhance the efficacy of gene therapies.